Celsius (NASDAQ:CELH) Announces Earnings Results

Celsius (NASDAQ:CELH) posted its quarterly earnings data on Tuesday. The company reported $0.27 EPS for the quarter, topping the consensus estimate of $0.20 by $0.07, Briefing.com reports. The firm had revenue of $355.70 million for the quarter, compared to the consensus estimate of $390.37 million. Celsius had a return on equity of 131.58% and a net margin of 17.21%. The business’s revenue for the quarter was up 36.9% compared to the same quarter last year. During the same quarter last year, the company earned $0.13 earnings per share.

Celsius Price Performance

NASDAQ:CELH opened at $77.13 on Thursday. The company has a market cap of $17.82 billion, a price-to-earnings ratio of 100.17, a PEG ratio of 2.22 and a beta of 1.93. Celsius has a 1 year low of $34.74 and a 1 year high of $99.62. The stock’s 50 day simple moving average is $81.42 and its two-hundred day simple moving average is $65.97.

Insider Activity

In related news, major shareholder Dean Desantis sold 100,000 shares of the business’s stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $95.75, for a total value of $9,575,000.00. Following the sale, the insider now owns 219,257 shares in the company, valued at $20,993,857.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In related news, major shareholder Dean Desantis sold 100,000 shares of Celsius stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $95.75, for a total value of $9,575,000.00. Following the completion of the transaction, the insider now owns 219,257 shares in the company, valued at $20,993,857.75. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, major shareholder William H. Milmoe sold 428,574 shares of the business’s stock in a transaction that occurred on Monday, May 6th. The stock was sold at an average price of $59.67, for a total value of $25,573,010.58. Following the sale, the insider now directly owns 23,750,163 shares in the company, valued at $1,417,172,226.21. The disclosure for this sale can be found here. In the last ninety days, insiders sold 2,043,363 shares of company stock worth $131,361,140. 2.20% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on CELH shares. Jefferies Financial Group raised their target price on shares of Celsius from $98.00 to $105.00 and gave the stock a “buy” rating in a research note on Monday, March 18th. Stifel Nicolaus lowered their target price on shares of Celsius from $95.00 to $85.00 and set a “buy” rating on the stock in a research note on Thursday, May 2nd. Wedbush reiterated an “outperform” rating and issued a $100.00 price target on shares of Celsius in a research note on Friday, May 3rd. Morgan Stanley reissued an “equal weight” rating and set a $75.00 price target on shares of Celsius in a report on Wednesday, March 27th. Finally, UBS Group dropped their price objective on Celsius from $99.00 to $92.00 and set a “buy” rating for the company in a research note on Wednesday. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $84.95.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.